Literature DB >> 7778670

Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo.

S Krajewski1, S Bodrug, M Krajewska, A Shabaik, R Gascoyne, K Berean, J C Reed.   

Abstract

The mcl-1 gene encodes an approximately 37-kd protein that has significant homology with Bcl-2, an inhibitor of programmed cell death that is expressed in many types of long-lived cells. In this study we determined the in vivo patterns of Mcl-1 protein production in normal human tissues by immunohistochemical means, using specific polyclonal antisera, and made comparisons with Bcl-2. Like Bcl-2, Mcl-1 immunostaining was observed in epithelial cells in a variety of tissues, including prostate, breast, endometrium, epidermis, stomach, intestine, colon, and respiratory tract. However, often the expression of mcl-1 and bcl-2 in complex epithelia occurred in gradients with opposing directions, such that Bcl-2 immunostaining tended to be higher in the less differentiated cells lining the basement membrane, whereas Mcl-1 immunostaining was more intense in the differentiated cells located in the upper layers of these epithelia. The in vivo patterns of mcl-1 and bcl-2 expression were also strikingly different in several other tissues as well. Within the secondary follicles of lymph nodes and tonsils, for example, germinal center lymphocytes were Mcl-1 positive but mostly lacked Bcl-2; whereas mantle zone lymphocytes expressed bcl-2 but not mcl-1. Intense Mcl-1 immunoreactivity was also detected in several types of neuroendocrine cells, including the adrenal cortical cells that are Bcl-2 negative, sympathetic neurons that also contain Bcl-2, a subpopulation of cells in the pancreatic islets, Leydig cells of the testis, and granulosa lutein cells of the ovarian corpus luteum but not in thyroid epithelium, which is strongly Bcl-2 positive. Little or no Mcl-1 was detected in neurons in the brain and spinal cord, in contrast to Bcl-2, which is present in several types of central nervous system neurons. Conversely, strong Mcl-1 immunostaining was found in cardiac and skeletal muscle, which contain comparatively less Bcl-2. Additional types of cells that are Bcl-2-negative but that expressed mcl-1 include chondrocytes and hepatocytes. These findings demonstrate that mcl-1 expression is widespread in vivo and imply that the Mcl-1 and Bcl-2 proteins fulfill different roles in the overall physiology of cell death regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778670      PMCID: PMC1870904     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

3.  The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.

Authors:  M P Bronner; C Culin; J C Reed; E E Furth
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

4.  Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma.

Authors:  M Negrini; E Silini; C Kozak; Y Tsujimoto; C M Croce
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

5.  Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

Authors:  F Pezzella; A G Tse; J L Cordell; K A Pulford; K C Gatter; D Y Mason
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

6.  Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

Authors:  S Krajewski; M Krajewska; A Shabaik; T Miyashita; H G Wang; J C Reed
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Ultrastructural localization of bcl-2 protein.

Authors:  P Monaghan; D Robertson; T A Amos; M J Dyer; D Y Mason; M F Greaves
Journal:  J Histochem Cytochem       Date:  1992-12       Impact factor: 2.479

8.  Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.

Authors:  J C Reed; D E Sabath; R G Hoover; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells.

Authors:  J E Reynolds; T Yang; L Qian; J D Jenkinson; P Zhou; A Eastman; R W Craig
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.

Authors:  J C Reed; L Meister; S Tanaka; M Cuddy; S Yum; C Geyer; D Pleasure
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

View more
  78 in total

1.  The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes.

Authors:  N Katoh; S Kraft; J H Wessendorf; T Bieber
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

Authors:  L A O'Reilly; L Cullen; J Visvader; G J Lindeman; C Print; M L Bath; D C Huang; A Strasser
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors.

Authors:  George Z Rassidakis; Raymond Lai; Timothy J McDonnell; Fernando Cabanillas; Andreas H Sarris; L Jeffrey Medeiros
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

4.  Cloning and characterization of chicken SPATA4 gene and analysis of its specific expression.

Authors:  Ming-Chao Xie; Chao Ai; Xiu-Mei Jin; Shang-Feng Liu; Shi-Xin Tao; Zan-Dong Li; Zhao Wang
Journal:  Mol Cell Biochem       Date:  2007-08-03       Impact factor: 3.396

5.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

6.  Mcl-1, an anti-apoptotic Bcl-2 family member, essentially overlaps with insulin-producing cells in neonatal nesidioblastosis.

Authors:  Makoto Sano; Emiko Hayashi; Hitohiko Murakami; Hiroshi Kishimoto; Ryuji Fukuzawa; Norimichi Nemoto
Journal:  Virchows Arch       Date:  2008-01-31       Impact factor: 4.064

7.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

8.  Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility.

Authors:  Sheng Wang; Yan Jiang; Jin Liu; Yuanyuan Zhao; Chan Xiang; Rong Ma; Haidong Gao; Li Jin; Fuchu He; Haijian Wang
Journal:  Tumour Biol       Date:  2014-05-23

9.  Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Janice A Dominov; Christine A Kostek; Jeffrey Boone Miller
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

10.  New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.

Authors:  Bulbul Pandit; Andrei L Gartel
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.